Found 51 matching trials
Temozolomide Alone or With Pegylated Interferon-Alpha 2b (PGI) in Melanoma Patients PHASE2 The goal of this clinical research study is to learn if temozolomide alone ...
Show More Location
University of Texas MD Anderson Cancer Center
Learn More & Join Trial
Safety and Efficacy of Pegylated IFN-alpha 2B Added to Dasatinib in Newly Diagnosed Chronic Phase Myeloid Leukemia PHASE2 Patients with newly diagnosed CML have excellent outcomes with tyrosine kin...
Show More Location
Helsinki University Central Hospital
Learn More & Join Trial
Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection PHASE3 Hepatitis C virus (HCV) infection is a leading cause of death and illness i...
Show More Learn More & Join Trial
Impact of Physician Directed Education on Patient Compliance With Hepatitis C Therapy PHASE4 The purpose of this study is to evaluate the impact of a physician directed...
Show More Location
California Liver Institute
Learn More & Join Trial
Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors PHASE1 This phase I trial is studying the side effects of decitabine when given to...
Show More Location
Nevada Cancer Institute-Summerlin Campus
Learn More & Join Trial
A Study of Low Dose Interferon Alpha Versus Hydroxyurea in Treatment of Chronic Myeloid Neoplasms PHASE3 The purpose of the study is to compare the efficacy and toxicity including ...
Show More Location
Dept of Hematology, Aalborg hospital
Learn More & Join Trial
Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL NA RATIONALE: PEG-interferon alfa-2b may interfere with the growth of cancer c...
Show More Location
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
Learn More & Join Trial
A Collaborative Trial in Injectors of Individualized Treatment for Genotype 2/3 PHASE4 This sudy will determine whether shortening treatment for hepatitis C is fe...
Show More Location
Hunter Pharmacotherapy
Learn More & Join Trial
Induction Chemotherapy (R-CHOP Vs. R-FC) Followed by Interferon Maintenance Versus Rituximab Maintenance in MCL PHASE3 The aim of this study is to answer the following independent questions in t...
Show More Location
General University Hospital, 1St Department of Medicine
Learn More & Join Trial
Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED) PHASE4 This is an Australian, open-label, multicenter, randomized, double-blind cl...
Show More Location
Multiple Locations
Learn More & Join Trial